Cognition Therapeutics Inc. conducted its Annual Meeting of Stockholders virtually on June 18, 2025. Peggy Wallace and Ellen B. Richstone were elected to the Board of Directors as Class I directors. Additionally, the appointment of Ernst & Young LLP as the independent registered public accounting firm for the 2025 fiscal year was ratified.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cognition Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-061142), on June 20, 2025, and is solely responsible for the information contained therein.